Wyss Center Neurotech Challenge: Can You Connect the Human Brain with Digital World?

The Wyss Center, a not-for-profit neurotechnology organization based in Geneva, Switzerland, has launched a global neurotech innovation challenge to connect the human brain with the digital world. The Challenge seeks the most disruptive new technologies for brain stimulation and neural signal recording. The goal is to develop technology with a clinical application that could help paralyzed people move, overcome depression or memory loss, restore vision or address other nervous system disorders.

Open to anyone, from anywhere in the world, the award will provide access to the expertise and technical facilities at the Wyss Center as well as funding to translate the successful idea from research concept into a clinical application.

Accommodation and salary for the project leader in the beautiful Lake Geneva region of Switzerland will be included in the award for a minimum of a year in addition to ongoing funding for the project.

The deadline for entries to the Wyss Center Neurotech Challenge is the 1st February 2017.

Proposals may be sent out for independent external review. A short list will be announced on February 14 and the winner will be announced in April 2017.

For further information, please visit:
http://www.wysscenter.ch/en/neurotech-challenge

About the Wyss Center for Bio and Neuroengineering
The Wyss Center provides the expertise, facilities and resources to accelerate the development of creative neuroscience research into clinical solutions for human benefit.

Based at Campus Biotech in Geneva Switzerland, the Wyss Center offers competitively awarded project funding for innovative neurotechnology research projects that have the potential to make substantial impact.

The Center provides access to advanced neuroscience and engineering facilities, as well as the integrated clinical, regulatory and business resources required to guide high risk, high return projects on their the complex journey from research to product.

The Wyss Center's unique interdisciplinary team of specialists, including research scientists, engineers, regulatory experts, business development specialists and clinicians, help to develop the products that will prevent, diagnose or treat nervous system disorders, or will lead to useful technology with the potential to improve lives.

The Center will support highly innovative neurotechnology projects from anywhere in the world as long as they fit the core mission to accelerate the development of neurotechnology for human benefit and make full use of the Center's capabilities and resources.

Most Popular Now

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

New AI Approach Paves Way for Smarter T-…

Researchers have harnessed the power of artificial intelligence (AI) to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...